Brinker Capital Investments, LLC Incyte Corp Transaction History

Brinker Capital Investments, LLC

  • $11.4 Billion
  • Q3 2025

A detailed history of Brinker Capital Investments, LLC transactions in Incyte Corp stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 7,974 shares of INCY stock, worth $830,492. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,974
Previous 12,096 34.08%
Holding current value
$830,492
Previous $823,000 17.86%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$67.27 - $86.96 $277,286 - $358,449
-4,122 Reduced 34.08%
7,974 $676,000
Q2 2025

Aug 27, 2025
BUY
$55.17 - $71.22 $481,413 - $621,465
8,726 Added 258.93%
12,096 $823,000
Q2 2025

Aug 14, 2025
SELL
$55.17 - $71.22 $348,012 - $449,255
-6,308 Reduced 65.18%
3,370 $229,000
Q1 2025

Jul 31, 2025
BUY
$60.0 - $75.26 $16,200 - $20,320
270 Added 2.87%
9,678 $586,000
Q4 2024

Jul 31, 2025
SELL
$65.08 - $83.38 $146,234 - $187,354
-2,247 Reduced 19.28%
9,408 $649,000
Q3 2024

Jul 31, 2025
BUY
$57.33 - $68.61 $668,181 - $799,649
11,655 New
11,655 $770,000
Q2 2024

Jul 31, 2025
SELL
$51.18 - $63.75 $743,543 - $926,160
-14,528 Closed
0 $0
Q1 2024

Jul 31, 2025
SELL
$56.55 - $66.59 $95,908 - $112,936
-1,696 Reduced 10.45%
14,528 $827,000
Q4 2023

Jul 31, 2025
SELL
$52.16 - $64.19 $538,395 - $662,569
-10,322 Reduced 38.88%
16,224 $1.02 Million
Q3 2023

Jul 31, 2025
BUY
$57.77 - $65.93 $176,082 - $200,954
3,048 Added 12.97%
26,546 $1.53 Million
Q2 2023

Jul 31, 2025
SELL
$60.95 - $75.51 $91,120 - $112,887
-1,495 Reduced 5.98%
23,498 $1.46 Million
Q1 2023

Jul 31, 2025
SELL
$70.23 - $86.01 $70,159 - $85,923
-999 Reduced 3.84%
24,993 $1.81 Million
Q4 2022

Feb 06, 2023
SELL
$67.18 - $84.11 $167,748 - $210,022
-2,497 Reduced 8.76%
25,992 $2.09 Million
Q3 2022

Nov 01, 2022
SELL
$66.18 - $82.86 $56,650 - $70,928
-856 Reduced 2.92%
28,489 $1.9 Million
Q2 2022

Jul 18, 2022
BUY
$66.18 - $83.18 $152,743 - $191,979
2,308 Added 8.54%
29,345 $2.23 Million
Q1 2022

May 16, 2022
SELL
$66.02 - $79.71 $237,011 - $286,158
-3,590 Reduced 11.72%
27,037 $2.15 Million
Q4 2021

Feb 08, 2022
BUY
$63.34 - $74.11 $153,409 - $179,494
2,422 Added 8.59%
30,627 $2.25 Million
Q2 2021

Aug 03, 2021
BUY
$79.87 - $87.53 $323,553 - $354,584
4,051 Added 16.77%
28,205 $2.37 Million
Q1 2021

May 12, 2021
SELL
$76.02 - $100.5 $1.68 Million - $2.22 Million
-22,066 Reduced 47.74%
24,154 $1.96 Million
Q4 2020

Feb 16, 2021
BUY
$80.74 - $97.7 $1.95 Million - $2.36 Million
24,108 Added 109.03%
46,220 $4.02 Million
Q3 2020

Dec 03, 2020
BUY
$85.07 - $109.69 $1.88 Million - $2.43 Million
22,112 New
22,112 $1.98 Million

Others Institutions Holding INCY

# of Institutions
826
Shares Held
205M
Call Options Held
638K
Put Options Held
635K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email